A coalition of 14 state attorneys general along with Pennsylvania’s governor has initiated a federal lawsuit challenging the Trump administration’s revisions to the federal childhood immunization schedule. The legal action, lodged in the US District Court for the Northern District of California, targets Health and Human Services Secretary Robert F. Kennedy Jr. and Acting Centers for Disease Control and Prevention Director Jayanta Bhattacharya. The central issue is a January decision that altered the status of seven vaccines, including those for influenza and COVID-19, shifting them from “universally recommended” to a “shared clinical decision-making” category.
The decision to amend the immunization guidelines has been defended by the HHS, which described the overhaul as the outcome of an extensive scientific review. Officials argued that the adaptation was a comparative examination of US immunization protocols against those of peer nations. Importantly, they assured stakeholders that insurance and existing federal programs would continue to cover all vaccines listed on the prior schedule.
The complaint propounds three legal theories under the Administrative Procedure Act. Firstly, it asserts that the decision process bypassed the Advisory Committee on Immunization Practices (ACIP) and disregarded substantial scientific evidence, thereby characterizing it as arbitrary and capricious. Secondly, the coalition argues the move contravenes federal statutes, including the Affordable Care Act and the Medicaid Act, which designate ACIP as the authority for formulating vaccine schedules. Lastly, the lawsuit disputes Secretary Kennedy’s dismissal of the 17 ACIP voting members and his subsequent appointments, alleging violations of the Federal Advisory Committee Act’s mandate for balanced and impartial committees.
California Attorney General Rob Bonta articulated the lawsuit’s contention that these changes could undermine vaccine confidence, thereby potentially reducing vaccination rates and increasing the prevalence of infectious diseases. This, in turn, may drive up state costs, particularly through Medicaid spending and efforts to counteract misinformation.
The state coalition is pressing for declaratory and injunctive relief, aiming to nullify the updated immunization schedule and the contested ACIP appointments. The lawsuit points to significant administrative costs and prospective increases in healthcare expenditures due to diseases preventable by the vaccines in question. There is also concern about the necessity to update state statutes that rely on ACIP recommendations.
This legal challenge emerges amidst broader disputes concerning vaccine policies in the United States. Notably, Florida recently announced its intention to abolish all vaccine mandates, and a federal lawsuit by medical organizations contests recent modifications to COVID-19 vaccine guidelines for pregnant women and healthy children. More details can be explored in an article on JURIST.